Canada’s Leading Research Universities

Developing talent, Driving innovation, Delivering impact.

To measure the severity of COVID-19, researchers create a tool that can pull an elusive marker from human blood

Posted onOctober 21, 2020

When COVID-19 attacks, the immune system produces a cytokine, or protein, called Interleukin-6 (IL-6), whose concentrations can offer vital information about a patient’s level and stage of infection.

But measuring the critical marker has been extremely challenging, given its nearly undetectable presence in the biological stew that makes up human blood. Existing technology has not been accurate or sensitive enough to measure concentrations of IL-6 well enough to be reliable, especially in low concentrations….

https://brighterworld.mcmaster.ca/articles/to-measure-the-severity-of-covid-19-researchers-create-a-tool-that-can-pull-an-elusive-marker-from-human-blood/

Read More Impact Stories

Posted onMarch 21, 2024
This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Posted onJanuary 24, 2024
A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Posted onJanuary 24, 2024
This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]